News 2015
An archive of Centre news from 2015
Stem cell transplantation does not lead to sustained improvement in Crohn's disease
Researchers, including CGEM’s Head of Gastroenterology Section Professor Jack Satsangi, have recently published results from the Autologous Stem Cell Transplantation International Crohn’s Disease (ASTIC): December 2015
BIOCYCLE and the SPARE trial at Edinburgh
Professor Jack Satsangi of CGEM is a co-applicant on a major new grant awarded as part of the European Commission’s Horizon 2020 programme to support the BIOCYCLE project: November 2015
UK Inflammatory Bowel Disease Investigator’s Day at IGMM
first UK Inflammatory Bowel Disease (IBD) Investigator’s Day was held at the IGMM building with the support of the Edinburgh Clinical Trials Unit and the British Society of Gastroenterology: November 2015
Professor Ralston honoured by the Faculty of Pharmaceutical Medicine
Professor Stuart Ralston, Head of the Rheumatology and Bone Disease unit within CGEM, has been made an Honorary Fellow of the Faculty of Pharmaceutical Medicine: November 2015
Gene study pinpoints process that triggers painful bone disease
Researchers at the Universities of Edinburgh and Dundee have pinpointed the mechanism by which a key gene contributes to the development of a painful bone disease: November 2015
Nicholas Ventham wins the National Scholar Award
CGEM’s Mr Nicholas Ventham was awarded the 2015 National Scholar Award from amongst all UK abstracts for the presentation on Epigenome-wide DNA methylation profiling in inflammatory bowel disease (OP064): November 2015
Gene study prompts bowel disease rethink
An international team of researchers investigating genetic variation in patients with inflammatory bowel disease have identified that genetic factors affecting the specific location of the inflammation in the gut may have implications for diagnosis and treatment of patients: October 2015
Whole genome-sequencing uncovers new genetic cause for osteoporosis
The Centre for Genomic and Experimental Medicine’s Professor Stuart Ralston and Dr Nerea Alonso, have been involved in an important study which has identified a novel gene that is implicated in osteoporosis, offering a potential target for treatment: September 2015
Researchers identify new drug target for serious heart and lung condition
A team of researchers, including Centre for Genomic and Experimental Medicine Director Professor Tim Aitman, has identified a gene that sheds new light on a potentially fatal heart and lung condition and could lead to a new treatment: August 2015
MRC Molecular Pathology Node: Edinburgh-St Andrews Consortium for Molecular Pathology, Informatics and Genome Sciences - £2m
MRC Molecular Pathology Node: Edinburgh-St Andrews Consortium for Molecular Pathology, Informatics and Genome Sciences - £2m: July 2015
IPSEN Prize for Neuronal Plasticity awarded to Professor David Porteous
The Fondation IPSEN ‘Neuronal Plasticity Prize’ has been awarded annually since 1990. The Jury highlights a field of neuroscience and typically three Laureates are recognised: July 2015
Osteogenesis Imperfecta Trial
Researchers in the centre are running a clinical trial to study the effects of a new combination of treatments for osteogenesis imperfecta: July 2015
Gene therapy hope for CF patients
Gene therapy can improve lung function in cystic fibrosis patients, a clinical trial has found: July 2015
Improved lung function
One hundred and thirty six patients aged 12 and over received monthly doses of either the therapy or a dummy treatment for one year: July 2015
Cystic fibrosis
Cystic fibrosis affects around 10,000 people in the UK and over 90,000 worldwide: July 2015
UK-wide trial
Patients from across England and Scotland participated in the trial and were treated in two centres, Royal Brompton Hospital in London and the Western General Hospital in Edinburgh: July 2015
CF Gene Therapy clinical trial news
The UK Cystic Fibrosis Gene Therapy Consortium has recently completed a Phase 2 study of gene therapy for the treatment of cystic fibrosis: May 2015
New CGEM Director
After 12 years as Director, Professor Porteous steps down in favour of Professor Tim Aitman with effect from 1st April 2015: April 2015